SAN MATEO, Calif., Sept. 16, 2009 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today announced that management will present at the UBS Global Life Sciences Conference in New York City on Tuesday, September 22nd at 1:30 p.m. Eastern Time.

A live audio webcast of the presentation will be available on the company's website homepage at www.paintrials.com. A replay of the audio webcast will continue to be available on the website for two weeks.

About Pain Therapeutics, Inc.

Pain Therapeutics, Inc. is a biopharmaceutical company that develops novel drugs. In addition to REMOXY(r), a unique abuse-resistant controlled-release oxycodone, the Company has three drug candidates in clinical programs, including a novel radio-labeled monoclonal antibody to treat metastatic melanoma, as well as PTI-202 and PTI-721. Pain Therapeutics is also working on a new treatment for patients with hemophilia.

CONTACT:  Pain Therapeutics, Inc.
          Judy Ishida, Administrative Manager
          650-645-1924
          IR@paintrials.com